InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.26
(
-0.76%
)
US TECH 100
19,652.00
(
-1.25%
)
Dow Jones
42,740.42
(
-0.75%
)
Brent Oil
74.31
(
-0.22%
)
Bitcoin
67,282.00
(
0.41%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

atglobe

Send PM Follow Ignore
Followers 5
Posts 163
Boards Moderated 0
Alias Born 08/26/2012

atglobe

Re: brucebill post# 103317

Friday, 12/13/2013 11:07:50 AM

Friday, December 13, 2013 11:07:50 AM

Post# of 158400
not only hema, but other technologies such as treating breast cancer and up to 30 technologies. Regen BioPharma identifies 30 promising technologies for rapid commercialization.


Once hema is a success then there should probably funding for treating breast cancers as well as other technology, and there was that what seems to be a unofficial report of BMSN partnering with Pfizer.

Maybe a large corporation would buy BMSN out, hence hiring the price of BMSN stock.

Medistem was a stem cell company run by I think the CEO of BMSN and it's stock reached at least a $1 so I hope BMSN will as well.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up